Regulation of ERK3/MAPK6 expression by BRAF
Klaus P. Hoeflich(Translational Research in Oncology), Somasekar Seshagiri(Molecular Biology Consortium)
Cited by 32
Related Papers
Recurrent R-spondin fusions in colon cancer
|Nature|2012|973
Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant Tumors
|PLoS ONE|2009|108
Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents
|Breast Cancer Research|2015|74
Conditional activation of Pik3caH1047R in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations
|Oncogene|2012|73
Phosphoproteomic characterization of DNA damage response in melanoma cells following MEK/PI3K dual inhibition
|Proceedings of the National Academy of Sciences|2013|56